What are the contraindications for a nerve block?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Contraindications for Nerve Blocks

Deep peripheral nerve blocks (infraclavicular, parasacral sciatic, posterior lumbar plexus) are absolutely contraindicated in patients taking P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) unless discontinued 5-7 days prior to the procedure. 1

Absolute Contraindications

Anticoagulation-Related (High-Risk Blocks Only)

Deep/non-compressible blocks are contraindicated in the following scenarios:

  • Active P2Y12 inhibitor therapy (clopidogrel, prasugrel, ticagrelor) without appropriate discontinuation periods 1

    • Clopidogrel: requires 5-day discontinuation
    • Prasugrel: requires 7-day discontinuation
    • Ticagrelor: requires 5-day discontinuation
  • Therapeutic anticoagulation unless dabigatran concentration is ≤30 ng/mL or appropriate reversal (idarucizumab) is administered 1, 2

  • Coagulopathy or bleeding disorders that cannot be corrected 1

Patient-Related Absolute Contraindications

  • Patient refusal 1
  • Active infection at the injection site 1
  • Very short life expectancy (for interventional pain procedures) 1

Relative Contraindications Requiring Risk-Benefit Assessment

Antiplatelet Therapy (Block Type-Dependent)

For deep/high-risk blocks (infraclavicular, parasacral sciatic, posterior lumbar plexus):

  • Aspirin monotherapy is a relative contraindication; may proceed only if benefit/risk ratio is favorable 1

For superficial/low-risk blocks (femoral, axillary, popliteal sciatic):

  • Mono or dual antiplatelet therapy may be acceptable with favorable benefit/risk ratio 1
  • These blocks can be compressed if bleeding occurs, making them safer in anticoagulated patients 1

Special Clinical Situations

  • COVID-19 infection: Nasal sphenopalatine ganglion blocks should be avoided due to aerosol generation risk 1

  • Medications increasing bleeding risk: Anticoagulants (warfarin, heparin), antiplatelet agents, and antiangiogenesis agents (bevacizumab) require careful assessment 1

  • Respiratory compromise risk: Avoid blocks that may impair respiratory function (interscalene, supraclavicular) in favor of alternatives (axillary, infraclavicular, superior trunk blocks) 1

Critical Safety Requirements

Mandatory Technical Standards

All nerve blocks (superficial or deep) must be performed with:

  • Ultrasound guidance to reduce local anesthetic systemic toxicity risk 1, 2
  • Experienced operator performing the technique 1
  • Calculated safe dose of local anesthetic based on patient weight 2, 3
  • Immediate resuscitation equipment availability 2, 3

Perineural Catheter Considerations

Catheter insertion and removal follow the same contraindications as initial block placement:

  • Must not compromise postoperative resumption of anticoagulants/antiplatelets 1
  • Removal requires optimal hemostatic conditions 1
  • Risk of infection, obstruction, migration, and accidental removal must be considered 4, 5

Common Pitfalls to Avoid

Do not assume aspirin is safe for all block types—it remains a relative contraindication for deep blocks requiring individual risk assessment 1

Do not perform deep blocks without knowing anticoagulation status—the inability to compress these areas makes hemorrhage potentially catastrophic 1

Do not proceed with blocks near the head/neck in COVID-19 patients without airborne precautions in addition to standard droplet precautions 1

Do not use general hemostasis guidelines for peribulbar blocks—compression is impossible if bleeding occurs, requiring special consideration despite low overall bleeding risk 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Peripheral Nerve Blocks for Short PFN Insertion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ultrasound-Guided Obturator Nerve Block Procedure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.